VEGF/VEGFR signalling as a target for inhibiting angiogenesis. - Wikidata - wikimedia - TriplyDB

VEGF/VEGFR signalling as a target for inhibiting angiogenesis.

VEGF/VEGFR signalling as a target for inhibiting angiogenesis.

http://www.wikidata.org/entity/Q36677407

about

Vascular endothelial growth factor inhibitors: investigational therapies for the treatment of psoriasis Dietary compound isoliquiritigenin inhibits breast cancer neoangiogenesis via VEGF/VEGFR-2 signaling pathway The proliferation of malignant melanoma cells could be inhibited by ranibizumab via antagonizing VEGF through VEGFR1.MMP-2 alters VEGF expression via alphaVbeta3 integrin-mediated PI3K/AKT signaling in A549 lung cancer cells.Curcumin attenuates angiogenesis in liver fibrosis and inhibits angiogenic properties of hepatic stellate cells New insights in synovial angiogenesis.Angiogenesis in rheumatoid arthritis.Angiogenesis and its targeting in rheumatoid arthritis HIF-VEGF pathways are critical for chronic otitis media in Junbo and Jeff mouse mutants.Targeting Angiogenesis in Rheumatoid Arthritis Indirubin derivative E804 inhibits angiogenesis.Pro-angiogenic activity of notoginsenoside R1 in human umbilical vein endothelial cells in vitro and in a chemical-induced blood vessel loss model of zebrafish in vivo.The Histone Methyltransferase Inhibitor BIX01294 Inhibits HIF-1α Stability and Angiogenesis.Sry-type HMG box 18 contributes to the differentiation of bone marrow-derived mesenchymal stem cells to endothelial cells.Synergistic Binding of Vascular Endothelial Growth Factor-A and Its Receptors to Heparin Selectively Modulates Complex Affinity.A high-affinity human/mouse cross-reactive monoclonal antibody, specific for VEGFR-2 linear and conformational epitopes.Gene regulatory network inference: evaluation and application to ovarian cancer allows the prioritization of drug targets.PKN3 is the major regulator of angiogenesis and tumor metastasis in mice Endogenous ribosomal protein L29 (RPL29): a newly identified regulator of angiogenesis in mice Tumor vessel-injuring ability improves antitumor effect of cytotoxic T lymphocytes in adoptive immunotherapy sMEK1 inhibits endothelial cell proliferation by attenuating VEGFR-2-dependent-Akt/eNOS/HIF-1α signaling pathways.Molecular imaging probes for diagnosis and therapy evaluation of breast cancer Tubeimoside-1 suppresses tumor angiogenesis by stimulation of proteasomal VEGFR2 and Tie2 degradation in a non-small cell lung cancer xenograft model A novel polysaccharide from Sargassum integerrimum induces apoptosis in A549 cells and prevents angiogensis in vitro and in vivo Discovering small molecule ligands of vascular endothelial growth factor that block VEGF-KDR binding using label-free microarray-based assays.Emerging drugs for targeted therapy of bladder cancer.Peroxisome proliferator-activated receptor-gamma ligands as investigational modulators of angiogenesis.YL529, a novel, orally available multikinase inhibitor, potently inhibits angiogenesis and tumour growth in preclinical models.Peroxisome Proliferator-Activated Receptor-gamma Ligands: Potential Pharmacological Agents for Targeting the Angiogenesis Signaling Cascade in Cancer.Proinflammatory role of vascular endothelial growth factor in the pathogenesis of rheumatoid arthritis: prospects for therapeutic intervention.Evolving strategies: future treatment of glioblastoma.Emerging therapies for the treatment of neovascular age related macular degeneration.Investigational VEGF antagonists for psoriasis.Novel investigational vascular endothelial growth factor (VEGF) receptor antagonists for psoriasis.SKLB610: a novel potential inhibitor of vascular endothelial growth factor receptor tyrosine kinases inhibits angiogenesis and tumor growth in vivo.Inhibition of angiogenesis as a new therapeutic target in the treatment of lepromatous leprosy.Vascular endothelial growth factor receptor-1 (VEGFR-1) expression in human corneal fibroblast decreased with age.Generation and characterization of a novel human IgG1 antibody against vascular endothelial growth factor receptor 2.Incisor degeneration in rats induced by vascular endothelial growth factor/fibroblast growth factor receptor tyrosine kinase inhibition.Anti-VEGFR2-interferon-α2 regulates the tumor microenvironment and exhibits potent antitumor efficacy against colorectal cancer.

P2860

Q22305863-BFAAC1E2-3C38-4D21-B248-65F48AA1B293 Q28385231-EF871EC7-B111-410D-BEC5-222D5843D350 Q33614283-8DFA75B8-B347-4832-80E3-F6DC1C2C1BBF Q33938788-1A25C2B5-191C-4E59-A45E-548C770E662A Q34011505-4C80A637-C83C-4EBF-ABD2-1B951005040A Q34022062-F4C7925A-9D94-4339-8BB8-C061E76BA86B Q34051829-583E076A-7FE8-472D-8712-F5B97A166D09 Q34051950-777C9770-EE7E-48D6-A787-5ED023DB51AF Q34058200-C024DE06-E765-43B0-9865-57849367DC81 Q34058895-550E6651-F731-4C6A-BA56-AEE1F19600C5 Q34254864-51EC1FAD-D7EE-4292-B81D-43322464C3D8 Q35532669-E85B6430-A582-4FCD-B285-231F905F4F08 Q35749723-81A330D9-E351-47ED-896A-01C4AA983C26 Q35776368-5AE0549C-27A9-40CF-8133-77CA7173C0D7 Q35783198-1F44050E-3DB2-450A-A5FB-B4774F5EB709 Q35828124-EA22486F-2286-4797-9EFD-D1B27A9589F1 Q36424741-0997AE17-1EA6-4845-B463-AF97821616FA Q36442867-30D0A616-56D0-44CF-BC00-DACC909D3B7A Q36486025-56B3DA39-C420-4E4B-8AF8-00F356893E47 Q36499639-39898B0C-41B6-40DF-BCFC-7EA0B8835511 Q36544702-FEFBE0F5-634E-4BE8-891E-502ACDE7FB55 Q36692448-C18A4405-73B5-465A-B747-C89AAEF11135 Q36905630-4917B241-0D5D-40ED-B401-082F75CFC560 Q36928661-88459F1F-7706-4941-8F21-7D20DF64A0EB Q36936860-45143677-1042-43BF-A553-EB3B98E006D1 Q36944022-8208E2D2-6BE4-4188-A4A7-C80035E6B840 Q36964693-40D18AAA-7BC7-4041-95DB-539DA1E8DEFC Q37122693-7886C880-321C-4EE6-97D0-E39CE9E6634A Q37157524-25B5989D-AC71-402A-92EB-3AF42F87BDAE Q37395327-F7984574-6C69-400F-9EB3-A509B4296612 Q37862235-4D3CC217-4CEB-43BC-93B7-B01C577ABBF6 Q37879168-5BB7CF4A-9955-4296-BBA4-B7D91A92D819 Q37956733-6FD9A63D-B788-4507-B957-0114D5B4572D Q38728552-4E36E246-18AB-4712-9570-688B006F7E34 Q39521060-B7608CA9-5B84-4C28-988E-C17D0BF60EBF Q40699468-975EB143-91D0-4676-9820-5DA63B3AECA2 Q42173109-655F6E90-F42F-4294-861D-27DF7CFAAA85 Q42801724-F726D811-7BED-4A87-9DEE-7559F928D283 Q43184381-0C453444-EE52-433B-8BCF-A315ED8EF444 Q44645655-6937A6D0-5AD7-48C2-98F0-26FBCE2DEC07

P2860

VEGF/VEGFR signalling as a target for inhibiting angiogenesis.

http://www.wikidata.org/entity/Q36677407

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

2007年论文

@zh

2007年论文

@zh-cn

name

VEGF/VEGFR signalling as a target for inhibiting angiogenesis.

@ast

VEGF/VEGFR signalling as a target for inhibiting angiogenesis.

@en

type

label

VEGF/VEGFR signalling as a target for inhibiting angiogenesis.

@ast

VEGF/VEGFR signalling as a target for inhibiting angiogenesis.

@en

prefLabel

VEGF/VEGFR signalling as a target for inhibiting angiogenesis.

@ast

VEGF/VEGFR signalling as a target for inhibiting angiogenesis.

@en

P1433

Q36677407-35D5274B-BB02-446B-998E-0B8A3CEAA8E9

P1476

Q36677407-1836A449-2E9D-4AF2-B8F1-A46285D2E16F

P2093

Q36677407-1BF06B4B-8CD7-4571-9617-557A7094747A

Q36677407-AF27C93D-7583-498F-99BB-C45F75C23A5F

Q36677407-B68B8491-FCE9-4966-9728-6F487379FA01

P2860

Q36677407-03448A50-FED2-4859-98D2-B5EFD998C999

Q36677407-036E8885-940E-4C37-8056-E60881F09C69

Q36677407-06B6A46F-5EFF-452E-8214-17D6933C2507

Q36677407-0736408B-DD81-47A9-8BF4-1E961482777B

Q36677407-0BC6B0F6-E550-4DFE-BAA1-4D002E67BB4A

Q36677407-0C4B4304-730E-45B1-B04E-98BDCDB922EF

Q36677407-0F1CC488-242E-4632-B5B5-FD9ED781433F

Q36677407-108D9651-B20F-405C-A4CE-3365FC33A8CE

Q36677407-114AC69D-6667-4F71-B257-1FB6D280D5A1

Q36677407-122A990E-E8EA-430A-84B3-D8ADF4FE6A70

P304

Q36677407-AD30E81B-4BB1-430B-9F60-9E0F353B93EF

P31

Q36677407-5596E687-57E8-4851-94FF-283D3FE3E70C

P356

Q36677407-F35D62A9-9D4A-4183-B0C6-0901ABF05082

P407

Q36677407-48386ACB-679C-4D94-A87A-73085D7A7D09

P433

Q36677407-302937B6-41B5-4872-AA06-DA4DCD05ECEA

P478

Q36677407-AC6D365E-BCB9-488F-96A0-174C42270C0B

P577

Q36677407-BD5757F7-39E2-4425-AC4F-BA40A634EA3B

P5875

Q36677407-FFE67598-32AD-49DC-8515-7C83A6F05C9F

P698

Q36677407-7C6CD849-5B67-4C18-923C-55B36CF5CD33

P356

13543784.16.1.83

P1433

Expert Opinion on Investigational Drugs

P1476

VEGF/VEGFR signalling as a target for inhibiting angiogenesis.

@en

P2093

Alex Kiselyov

http://www.w3.org/2001/XMLSchema#string

Konstantin V Balakin

http://www.w3.org/2001/XMLSchema#string

Sergey E Tkachenko

http://www.w3.org/2001/XMLSchema#string

P2860

The Hallmarks of Cancer

Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor

The crystal structure of placental growth factor in complex with domain 2 of vascular endothelial growth factor receptor-1

Crystal structure at 1.7 A resolution of VEGF in complex with domain 2 of the Flt-1 receptor

Inhibition of vascular endothelial cell growth factor activity by an endogenously encoded soluble receptor

The protein kinase complement of the human genome

VEGF-Trap: a VEGF blocker with potent antitumor effects.

Processing of VEGF-A by matrix metalloproteinases regulates bioavailability and vascular patterning in tumors

Vascular endothelial growth factor: crystal structure and functional mapping of the kinase domain receptor binding site

Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer

P304

83-107

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/13543784.16.1.83

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

16

http://www.w3.org/2001/XMLSchema#string

P577

2007-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6643421

http://www.w3.org/2001/XMLSchema#string

P698

17155856

http://www.w3.org/2001/XMLSchema#string